Cardiogenesis Starts Clinical Trial For Its Pearl Robotic TMR System
This article was originally published in The Gray Sheet
Executive Summary
Cardiogenesis is developing a minimally-invasive transmyocardial revascularization (TMR) procedure for use on its Pearl 5.0 robotic laser delivery system, which is expected to receive FDA clearance within a few months